Ozempic Bull**** (again)
Mandelin Rain said:
Especially with the UA companies being chronically "understaffed" (sarcastic air quotes) and requiring 14 days for review and then 7 days to schedule a peer to peer.
This should be illegal. It's a delay tactic for cancer care. Obviously that sweet insurer lobby money will keep the grift going.
Click to expand...
Our system can’t even do anything about the ozempic situation which threatens to make us insolvent. You think policymakers are going to fix prior auth for radiation? Our form of medicine, is...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 7, 2024 Category: Universities & Medical Training Authors: MidwestRadOnc Tags: Radiation Oncology Source Type: forums
Re: Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England
(Source: BMJ Comments)
Source: BMJ Comments - February 5, 2024 Category: General Medicine Source Type: forums
Job search limited to a few metro areas - advice appreciated!
Hello all,
I'm a second year fellow (no visa sponsorship required) looking to join a community or hybrid heme/onc practice. Due to my spouse's job, I am constrained to practices ideally within 1 hour of the following metro areas:
- Dallas/FW
- Denver
- Seattle
- Portland
I don't have any local contacts in these areas so I'm hoping some of you may be able to advise me on general salary expectations (all these areas are desirable and I know there can be quite a bit of heterogeneity between...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 4, 2024 Category: Universities & Medical Training Authors: Dohle Body Tags: Hematology / Oncology Source Type: forums
financial viability study for a new RT department
Dear colleagues,
i would be grateful if you can recommend any useful resource, articles, tutorial etc ... that might help me to prepare a financial viability study. some references where i can find an average estimate of ROI in radiation therapy, average operational cost per session .... (Source: Student Doctor Network)
Source: Student Doctor Network - February 1, 2024 Category: Universities & Medical Training Authors: Kroll2013 Tags: Radiation Oncology Source Type: forums
Re: Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - February 1, 2024 Category: General Medicine Source Type: forums
Palmetto/CMS/LCD not covering R sided IMRT APBI
Has anyone else seen this?
I'm seeing that in spite of NCCN saying 30/5 IMRT is the preferred APBI approach, Palmetto (the LCD for a huge chunk of the country) is not covering IMRT even for APBI in R sided breast cases.
Is this correct?
Is this something that is amenable to any appeals?
Absolutely insane that a relatively cheap treatment, proven in a phase 3 trial, listed in NCCN guidelines as the preferred technique/fractionation....is not paid for by cms. (Source: Student Doctor Network)
Source: Student Doctor Network - January 31, 2024 Category: Universities & Medical Training Authors: BobbyHeenan Tags: Radiation Oncology Source Type: forums
what is your thought about this drug pricing article?
If I interpret the data correctly, the difference in % is huge, not sure how to interpret the dollar difference. How can physician practice survive and still get a good pay given the much upper hand hospital systems have in profiting from the drug? Would love to know others perspective/experience. (Source: Student Doctor Network)
Source: Student Doctor Network - January 31, 2024 Category: Universities & Medical Training Authors: HemOncCheng Tags: Hematology / Oncology Source Type: forums
Finding all cases: not the goal of cancer screening
(Source: BMJ Comments)
Source: BMJ Comments - January 29, 2024 Category: General Medicine Source Type: forums
Re: Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - January 29, 2024 Category: General Medicine Source Type: forums
High Risk Prostate - GETUG 18 - Conventional fractionation - Improved OS
Conventional EBRT to 80 Gy with 3 yrs ADT improves OS in high risk prostate ca.
Overall survival was improved, ergo a surrogate for OS in prostate radiotherapy not needed.
I imagine these results are going to stir the pot in the rad onc community.
Conventional fractionation has the data. Hypofractionation does not - would "not be proper to do so".
Hats off to the French.
ASCO GU 2024 GETUG 18
The abstract:
ASCO 2024
Long-term results of dose escalation...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - January 27, 2024 Category: Universities & Medical Training Authors: SneakyBooger Tags: Radiation Oncology Source Type: forums
what steps to take to become a doctor who does research
$(document).ready(function() {
window.TSRDataLayer = window.TSRDataLayer || [];
window.TSRDataLayer.push({
event: {
eventType: 'visible',
eventData: {
group: 'pm',
section: 'pm-content',
pmId: ,
pmTextId: ,
}
}
})
$("#reply_pm .post-content a").on("click", function() {
window.TSRDataLayer.push({
event: {
eventType: 'click',
eventData: {
group: 'pm',
section: 'pm-content',
item: 'link',
url: this.href,
pmId: ,
...
Source: The Student Room - January 25, 2024 Category: Universities & Medical Training Authors: artful_lounger Tags: Medicine Source Type: forums
Billing-new code
Anyone have experience with the G2211 code- do you use it with new patients or follow ups or both? Which types of patients are you using it for? Thanks! (Source: Student Doctor Network)
Source: Student Doctor Network - January 25, 2024 Category: Universities & Medical Training Authors: hehe5347 Tags: Hematology / Oncology Source Type: forums
L1 fx 50% loss, 8 M out, not healing, Kypho?
L1 fx 50% loss, 8 M out, not healing, persistent edema, Kypho?. no h/o malignancy. known osteoporosis
for Kypho, is there a hard deadline after fx. ? (Source: Student Doctor Network)
Source: Student Doctor Network - January 24, 2024 Category: Universities & Medical Training Authors: specepic Tags: Pain Medicine Source Type: forums
question about mid-levels
Can anyone chime in on how the reimbursement rates look for mid levels in community practice? I've read 85% of what MD bills. Not sure how this is working on it everyday practice.
Are midlevels able to see a new patient, plan, write chemo with MD approval if MD is comfortable with this approach?
How many patients per day do midlevels typically see ? I am assuming there is a range from the newly licensed to the 30+ year vet.
How many midlevels are you normally overseeing any given day? (Source: Student Doctor Network)
Source: Student Doctor Network - January 19, 2024 Category: Universities & Medical Training Authors: txmedstudent87 Tags: Hematology / Oncology Source Type: forums
Does pathology morphology matter anymore?
Greetings from the Pathology Forum! As pathologists, we have seen an increased trend towards oncologists just focusing on molecular test results rather than the standard pathology report. See below. What are you thoughts? Does morphology (ie. anatomic pathology diagnosis) matter anymore?
Digital pathology is just pathology, but does it matter anymore? | Tissuepathology.com
Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% o...
Source: Student Doctor Network - January 19, 2024 Category: Universities & Medical Training Authors: caffeinegirl Tags: Hematology / Oncology Source Type: forums
